David Mandl on Mon, 15 Apr 2002 18:38:02 +0200 (CEST) |
[Date Prev] [Date Next] [Thread Prev] [Thread Next] [Date Index] [Thread Index]
[Nettime-bold] Monsanto Says Crops May Contain Genetically-Modified Canola Seed |
One of the arguments (though not the strongest) against G.M. technology is that there's almost certain to be an accident eventually, and a G.M.-related accident could be far worse than any of the many drug- and chemical-related accidents we've seen in the past. (Those drugs and chemicals, too, were invented and tested by the world's greatest scientific minds.) Well, forget "eventually," as there already seems to be an accident every month, and this technology is barely off the ground yet. Here's a story on the latest from today's WSJ. Note the industry tactic of requesting retroactive changes to the already lax law because they can't or won't keep their experiments under control. This illustrates the classic gradualist approach that they'll use to spread G.M. technology. --Dave. -------------------- April 15, 2002 HEALTH Monsanto Says Crops May Contain Genetically-Modified Canola Seed By SCOTT KILMAN and JILL CARROLL Staff Reporters of THE WALL STREET JOURNAL Monsanto Co. believes that some of its canola seed might contain genetically modified material that isn't federally approved. Angling to avoid a massive recall of food products, the company is asking regulators to forgive any presence of it. The St. Louis-based biotechnology company has yet to detect it in the seeds it has tested, but says trace amounts of the material were found last year in Canadian seed, leading it to believe the same is possible in the U.S. In conceding that for three years U.S. farmers have been planting canola seed that may contain certain genetic material that was never meant to leave the laboratory, Monsanto has become the latest example of the biotechnology industry failing to control plants whose genes it has altered. Monsanto, which is 85% owned by drug maker Pharmacia Corp., Peapack, N.J., insists that the canola seed in question is safe to consume. But genetically modified food is an emotional issue for many consumers. And Monsanto's admission is sure to fuel consumer skepticism and inflame opponents of gene-altered crops, who object to the idea of tinkering with nature and who worry about cross-pollination with other crops. Clearly, Monsanto is hoping to avoid a repeat of the biotechnology industry's most embarrassing and costly episode, in which a variety of genetically modified corn approved only for livestock consumption and industrial use found its way into the human food supply. Called StarLink, the corn was detected in more than 300 products with brand names such as Kraft and Taco Bell, resulting in enormous recalls in 2000. At least one group opposed to genetically modified food, having learned about Monsanto's request, intends to fight it and to publicize its implications -- that the biotechnology industry can't always control the spread of its own creations. "This is genetic pollution," says Joseph Mendelson, legal director of the Center for Food Safety, a Washington advocacy group. The U.S. Department of Agriculture is leaning toward granting Monsanto's unusual request, which the company made in a November letter, but hasn't done so formally. The Food and Drug Administration is reviewing safety data from Monsanto. If Monsanto fails to receive federal approval for the altered organism, known as GT200, the discovery of its presence in U.S. canola wouldn't necessarily mandate a food recall, as the laws don't spell it out. But antibiotechnology groups would likely clamor for a recall. The situation is potentially a big headache for the U.S. food industry, because canola oil is a basic ingredient in hundreds of products. Canola's popularity has increased because it is lower in saturated fats than other edible oils. About two-thirds of the canola crops in the U.S. are already genetically modified. A spokesman for ConAgra Foods Inc., maker of Wesson oil, says the company doesn't screen its canola oil for genetically modified ingredients. He wouldn't comment on what the company would do if GT200 is detected in its supplies. Monsanto created GT200 in the 1990s while trying to produce a seed capable of growing into a canola plant invulnerable to Roundup, a Monsanto weedkiller. Such a plant would enable farmers to liberally apply the herbicide without damaging their crop. Ultimately, Monsanto chose to develop and market canola seed that had been modified differently. Called RT73, it is also invulnerable to Roundup. Deciding that the second version performed better, Monsanto sought and received federal approval to market RT73 canola seed. Federal scrutiny is required of any plant containing a foreign gene. Monsanto inserted genes from microorganisms into both versions of its canola seed. But in the November letter to the USDA, Monsanto said that GT200 "has the potential to be present in low, adventitious levels in commercial canola varieties." A majority of the 1.5 million acres of canola fields in the U.S. are believed to be planted with seed containing Monsanto's federally cleared Roundup-tolerant gene. Last year, the GT200 version showed up in Canadian canola seed, forcing Monsanto to recall hundreds of tons of it. Although Monsanto had sought and received Canadian approval for GT200, the recall was necessary because Canada exports huge amounts of canola to Japan, which hadn't approved GT200. Monsanto says it never sold the GT200 version commercially in Canada and isn't sure why it wound up in canola seed there. In the corn-contamination case of two years ago, StarLink's inventor, the cropscience division of French pharmaceutical giant Aventis SA, had to stop selling the seed and set aside $100 million ($88 million) to compensate food companies and growers for their costs. The fallout was widespread. A market exploded for food products free of genetically modified ingredients. Some farmers got cold feet about jumping into the biotech era. Wheat growers, for example, are telling Monsanto to proceed slowly with plans to supply them with genetically modified seeds. The Aventis cropscience division is being sold to German pharmaceutical giant Bayer AG. The biotechnology industry concedes the primary point of its opponents -- that crops mate too freely to keep genetically modified versions entirely separate. The wind and insects can carry the pollen of a genetically modified plant great distances to where it isn't wanted: an organic farm, for instance. The pollen from a genetically modified corn plant can fertilize corn that wasn't intended to be bioengineered. The problem extends to genetically modified crops that are legal but unwanted by a certain segment of consumers. A Wall Street Journal laboratory investigation last year of 20 products labeled as containing no genetically modified ingredients found evidence of the material in 16 of them. "As we see more and more varieties come out ... you might find trace amounts [of bioengineered ingredients] in food that didn't go through the full regulatory measure," says Michael P. Phillips of the Biotechnology Industry Organization, an industry trade group. But rather than hysterical reactions, the industry argues that government and society should accept trace-level contaminations. Officials of Monsanto, Aventis and other crop biotech companies want a new policy from the White House that would allow for the accidental presence of trace amounts of some genetically modified materials in seed and food. But the Bush administration couldn't do that without setting off protests from antibiotechnology groups. "We don't want the federal government to insulate the crop-biotechnology industry from liability," said Mr. Mendelson of the Center for Food Safety. -- Dave Mandl dmandl@panix.com davem@wfmu.org http://www.wfmu.org/~davem _______________________________________________ Nettime-bold mailing list Nettime-bold@nettime.org http://amsterdam.nettime.org/cgi-bin/mailman/listinfo/nettime-bold